Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus

M. Grinnell, A. Bath, D. DiMaio, T. Hultgren, M. Hearth-Holmes

Research output: Contribution to journalArticle

Abstract

Livedoid vasculopathy (LV) is a small vessel occlusive disease that can present with a painful purpuric eruption. Predominantly affecting young women, LV has been associated with hypercoagulable states and antiphospholipid syndrome. We present an unusual case of LV occurring in the setting of acute kidney injury secondary to lupus nephritis. It is important to differentiate LV from vasculitis as the treatment recommendation centers on anticoagulation therapy rather than immunosuppression. Additionally, antiphospholipid syndrome should be ruled out in cases of systemic lupus erythematosus with LV due to risk of thrombotic events.

Original languageEnglish (US)
Pages (from-to)1013-1016
Number of pages4
JournalLupus
Volume28
Issue number8
DOIs
StatePublished - Jul 1 2019

Fingerprint

Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Lupus Nephritis
Vasculitis
Acute Kidney Injury
Immunosuppression
Therapeutics

Keywords

  • Lupus nephritis
  • antiphospholipid syndrome
  • lupus vasculitis
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus. / Grinnell, M.; Bath, A.; DiMaio, D.; Hultgren, T.; Hearth-Holmes, M.

In: Lupus, Vol. 28, No. 8, 01.07.2019, p. 1013-1016.

Research output: Contribution to journalArticle

Grinnell, M. ; Bath, A. ; DiMaio, D. ; Hultgren, T. ; Hearth-Holmes, M. / Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus. In: Lupus. 2019 ; Vol. 28, No. 8. pp. 1013-1016.
@article{066ab711357b4ffca631868e78be32c2,
title = "Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus",
abstract = "Livedoid vasculopathy (LV) is a small vessel occlusive disease that can present with a painful purpuric eruption. Predominantly affecting young women, LV has been associated with hypercoagulable states and antiphospholipid syndrome. We present an unusual case of LV occurring in the setting of acute kidney injury secondary to lupus nephritis. It is important to differentiate LV from vasculitis as the treatment recommendation centers on anticoagulation therapy rather than immunosuppression. Additionally, antiphospholipid syndrome should be ruled out in cases of systemic lupus erythematosus with LV due to risk of thrombotic events.",
keywords = "Lupus nephritis, antiphospholipid syndrome, lupus vasculitis, systemic lupus erythematosus",
author = "M. Grinnell and A. Bath and D. DiMaio and T. Hultgren and M. Hearth-Holmes",
year = "2019",
month = "7",
day = "1",
doi = "10.1177/0961203319847274",
language = "English (US)",
volume = "28",
pages = "1013--1016",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus

AU - Grinnell, M.

AU - Bath, A.

AU - DiMaio, D.

AU - Hultgren, T.

AU - Hearth-Holmes, M.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Livedoid vasculopathy (LV) is a small vessel occlusive disease that can present with a painful purpuric eruption. Predominantly affecting young women, LV has been associated with hypercoagulable states and antiphospholipid syndrome. We present an unusual case of LV occurring in the setting of acute kidney injury secondary to lupus nephritis. It is important to differentiate LV from vasculitis as the treatment recommendation centers on anticoagulation therapy rather than immunosuppression. Additionally, antiphospholipid syndrome should be ruled out in cases of systemic lupus erythematosus with LV due to risk of thrombotic events.

AB - Livedoid vasculopathy (LV) is a small vessel occlusive disease that can present with a painful purpuric eruption. Predominantly affecting young women, LV has been associated with hypercoagulable states and antiphospholipid syndrome. We present an unusual case of LV occurring in the setting of acute kidney injury secondary to lupus nephritis. It is important to differentiate LV from vasculitis as the treatment recommendation centers on anticoagulation therapy rather than immunosuppression. Additionally, antiphospholipid syndrome should be ruled out in cases of systemic lupus erythematosus with LV due to risk of thrombotic events.

KW - Lupus nephritis

KW - antiphospholipid syndrome

KW - lupus vasculitis

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85066955643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066955643&partnerID=8YFLogxK

U2 - 10.1177/0961203319847274

DO - 10.1177/0961203319847274

M3 - Article

C2 - 31126212

AN - SCOPUS:85066955643

VL - 28

SP - 1013

EP - 1016

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 8

ER -